Jacqueline Ros

544 total citations
12 papers, 444 citations indexed

About

Jacqueline Ros is a scholar working on Genetics, Hematology and Physiology. According to data from OpenAlex, Jacqueline Ros has authored 12 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 5 papers in Hematology and 4 papers in Physiology. Recurrent topics in Jacqueline Ros's work include Hemoglobinopathies and Related Disorders (6 papers), Iron Metabolism and Disorders (5 papers) and Neuroscience and Neuropharmacology Research (3 papers). Jacqueline Ros is often cited by papers focused on Hemoglobinopathies and Related Disorders (6 papers), Iron Metabolism and Disorders (5 papers) and Neuroscience and Neuropharmacology Research (3 papers). Jacqueline Ros collaborates with scholars based in Switzerland, United Kingdom and United States. Jacqueline Ros's co-authors include Marianne Fillenz, Hans‐Peter Landolt, Beat Alessandri, Aminadav Mendelowitsch, O. Gratzl, Marie‐Françoise Ritz, H. Langemann, Suporn Chuncharunee, Antonis Kattamis and Zeynep Karakaş and has published in prestigious journals such as Blood, Brain Research and Journal of Neurochemistry.

In The Last Decade

Jacqueline Ros

12 papers receiving 435 citations

Peers

Countries citing papers authored by Jacqueline Ros

Since Specialization

Citations

This map shows the geographic impact of Jacqueline Ros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacqueline Ros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacqueline Ros more than expected).

Fields of papers citing papers by Jacqueline Ros

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacqueline Ros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacqueline Ros. The network helps show where Jacqueline Ros may publish in the future.

Co-authorship network of co-authors of Jacqueline Ros

This figure shows the co-authorship network connecting the top 25 collaborators of Jacqueline Ros. A scholar is included among the top collaborators of Jacqueline Ros based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacqueline Ros. Jacqueline Ros is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Deferasirox demonstrates a dose‐dependent reduction in liver iron concentration and consistent efficacy across subgroups of non‐transfusion‐dependent thalassemia patients 2013 ·American Journal of Hematology ·Alì Taher, John B. Porter, Vip Viprakasit, Antonis Kattamis, Suporn Chuncharunee, Pranee Sutcharitchan, Noppadol Siritanaratkul, Renzo Galanello, Zeynep Karakaş, Tomasz Lawniczek, Dany Habr, Jacqueline Ros, Yiyun Zhang, Maria Domenica Cappellini	15
2	Deferasirox effectively reduces iron overload in non-transfusion-dependent thalassemia (NTDT) patients: 1-year extension results from the THALASSA study 2013 ·Annals of Hematology ·Alì Taher, John B. Porter, Vip Viprakasit, Antonis Kattamis, Suporn Chuncharunee, Pranee Sutcharitchan, Noppadol Siritanaratkul, Renzo Galanello, Zeynep Karakaş, Tomasz Lawniczek, Dany Habr, Jacqueline Ros, Zewen Zhu, Maria Domenica Cappellini	58
3	Deferasirox reduces iron overload significantly in nontransfusion-dependent thalassemia: 1-year results from a prospective, randomized, double-blind, placebo-controlled study 2012 ·Blood ·Alì Taher, John B. Porter, Vip Viprakasit, Antonis Kattamis, Suporn Chuncharunee, Pranee Sutcharitchan, Noppadol Siritanaratkul, Renzo Galanello, Zeynep Karakaş, Tomasz Lawniczek, Jacqueline Ros, Yiyun Zhang, Dany Habr, Maria Domenica Cappellini	109
4	Reduction in liver iron concentration is consistent across subgroups of non-transfusion-dependent thalassemia patients treated with deferasirox : results from the 1-year thalassa study 2012 ·Alì Taher, John B. Porter, Vip Viprakasit, Antonis Kattamis, Suporn Chuncharunee, Pranee Sutcharitchan, Noppadol Siritanaratkul, R. Galanello, Zeynep Karakaş, Tomasz Lawniczek, Dany Habr, Jacqueline Ros, (unknown), (unknown)	2
5	Deferasirox Continues to Reduce Iron Overload in Non-Transfusion-Dependent Thalassemia: A One-Year, Open-Label Extension to a One-Year, Randomized, Double-Blind, Placebo-Controlled Study (THALASSA) 2012 ·Blood ·Alì Taher, John B. Porter, Vip Viprakasit, Antonis Kattamis, Suporn Chuncharunee, Pranee Sutcharitchan, Noppadol Siritanaratkul, Renzo Galanello, Zeynep Karakaş, Tomasz Lawniczek, Dany Habr, Jacqueline Ros, Zewen Zhu, Maria Domenica Cappellini	4
6	Deferasirox Significantly Reduces Liver Iron Concentration In Non-Transfusion-Dependent Thalassemia Patients with Iron Overload: Results From the 1-Year Randomized, Double-Blind, Placebo-Controlled Phase II THALASSA Study 2011 ·Blood ·Alì Taher, John B. Porter, Vip Viprakasit, Antonis Kattamis, Suporn Chuncharunee, Pranee Sutcharitchan, (unknown), Renzo Galanello, Zeynep Karakaş, Tomasz Lawniczek, Jacqueline Ros, Yiyun Zhang, Dany Habr, Maria Domenica Cappellini	2
7	P3‐275: Optimization of the treatment regimen with active Aß immunotherapy CAD106 in alzheimer patients 2010 ·Alzheimer s & Dementia ·Ana Graf, Niels Andreasen, Marie‐Emmanuelle Riviere, Jacqueline Ros, (unknown), Jeffrey Sevigny, Peter Quarg, Angelika Caputo, Luca A. Finelli, Bengt Winblad, Georges Imbert	2
8	Safety and Tolerability of the Rivastigmine Patch 2009 ·Alzheimer Disease & Associated Disorders ·George T. Grossberg, Carl Sadowsky, Hans Förstl, Lutz Frölich, (unknown), Sibel Tekin, (unknown), Jacqueline Ros, Jean‐Marc Orgogozo	36
9	Glutamate infusion coupled with hypoxia has a neuroprotective effect in the rat 2002 ·Journal of Neuroscience Methods ·Jacqueline Ros, Deborah Jones, (unknown), Beat Alessandri, Martyn G. Boutelle, Hans‐Peter Landolt, Marianne Fillenz	8
10	Lactate reduces glutamate‐induced neurotoxicity in rat cortex 2001 ·Journal of Neuroscience Research ·Jacqueline Ros, (unknown), Beat Alessandri, Hans‐Peter Landolt, Marianne Fillenz	92
11	17β-Estradiol reduces cortical lesion size in the glutamate excitotoxicity model by enhancing extracellular lactate: a new neuroprotective pathway 2001 ·Brain Research ·Aminadav Mendelowitsch, Marie‐Françoise Ritz, Jacqueline Ros, H. Langemann, O. Gratzl	81
12	Dynamic Changes in Glucose and Lactate in the Cortex of the Freely Moving Rat Monitored Using Microdialysis 2000 ·Journal of Neurochemistry ·Deborah Jones, Jacqueline Ros, Hans‐Peter Landolt, Marianne Fillenz, Martyn G. Boutelle	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact